These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 17969067)

  • 1. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?
    Roayaie K; Feng S
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S36-43. PubMed ID: 17969067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria.
    De Giorgio M; Vezzoli S; Cohen E; Armellini E; Lucà MG; Verga G; Pinelli D; Nani R; Valsecchi MG; Antolini L; Colledan M; Fagiuoli S; Strazzabosco M
    Liver Transpl; 2010 Apr; 16(4):503-12. PubMed ID: 20373461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.
    Pelletier SJ; Fu S; Thyagarajan V; Romero-Marrero C; Batheja MJ; Punch JD; Magee JC; Lok AS; Fontana RJ; Marrero JA
    Liver Transpl; 2009 Aug; 15(8):859-68. PubMed ID: 19642139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.
    Piscaglia F; Camaggi V; Ravaioli M; Grazi GL; Zanello M; Leoni S; Ballardini G; Cavrini G; Pinna AD; Bolondi L
    Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of liver transplantation: with or without Milan criteria?
    Mazzaferro V
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S44-7. PubMed ID: 17969068
    [No Abstract]   [Full Text] [Related]  

  • 7. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
    Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy.
    Yao FY; Bass NM; Nikolai B; Merriman R; Davern TJ; Kerlan R; Ascher NL; Roberts JP
    Liver Transpl; 2003 Jul; 9(7):684-92. PubMed ID: 12827553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
    Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M
    Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current controversies surrounding liver transplantation for hepatocellular carcinoma.
    Silva MF; Wigg AJ
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1217-26. PubMed ID: 20594247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system.
    Adler M; De Pauw F; Vereerstraeten P; Fancello A; Lerut J; Starkel P; Van Vlierberghe H; Troisi R; Donckier V; Detry O; Delwaide J; Michielsen P; Chapelle T; Pirenne J; Nevens F
    Liver Transpl; 2008 Apr; 14(4):526-33. PubMed ID: 18383082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era.
    Ravaioli M; Grazi GL; Ercolani G; Cescon M; Del Gaudio M; Zanello M; Ballardini G; Varotti G; Vetrone G; Tuci F; Lauro A; Ramacciato G; Pinna AD
    Transplantation; 2006 Feb; 81(4):525-30. PubMed ID: 16495798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list.
    Toso C; Dupuis-Lozeron E; Majno P; Berney T; Kneteman NM; Perneger T; Morel P; Mentha G; Combescure C
    Hepatology; 2012 Jul; 56(1):149-56. PubMed ID: 22271250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: Ablate and wait versus rapid transplantation.
    Roberts JP; Venook A; Kerlan R; Yao F
    Liver Transpl; 2010 Aug; 16(8):925-9. PubMed ID: 20658555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy.
    Yao FY; Bass NM; Ascher NL; Roberts JP
    Liver Transpl; 2004 May; 10(5):621-30. PubMed ID: 15108253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN; Perkins JD; Carithers RL
    Gastroenterology; 2008 May; 134(5):1342-51. PubMed ID: 18471511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Huang YH; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2004 Dec; 10(12):1507-13. PubMed ID: 15558587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for hepatocellular carcinoma in Asia.
    de Villa V; Lo CM
    Oncologist; 2007 Nov; 12(11):1321-31. PubMed ID: 18055852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for hepatocellular carcinoma.
    Kurtovic J; Riordan SM; Williams R
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):147-60. PubMed ID: 15757810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation therapy in containing extension of hepatocellular carcinoma: a simulative analysis of dropout from the waiting list for liver transplantation.
    Yamashiki N; Tateishi R; Yoshida H; Shiina S; Teratani T; Sato S; Mine N; Kondo Y; Kawabe T; Omata M
    Liver Transpl; 2005 May; 11(5):508-14. PubMed ID: 15838878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.